Office of the Director; Notice of Meeting, 17847 [2017-07427]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 70 / Thursday, April 13, 2017 / Notices
Dated: April 10, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07508 Filed 4–12–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Loan Repayment
Application Review.
Date: April 27, 2017.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: John F. Connaughton,
Ph.D., Chief, Scientific Review Branch,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7007, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7797, connaughtonj@
extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity Policy and Program Evaluation.
Date: April 28, 2017.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
VerDate Sep<11>2014
17:51 Apr 12, 2017
Jkt 241001
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: April 10, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07510 Filed 4–12–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of a meeting of the NIH
Clinical Center Research Hospital
Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The portion of the meeting devoted to
the identification and evaluation of
specific candidates for consideration for
leadership positions in the Clinical
Center will be closed to the public in
accordance with the provisions set forth
in section 552b(c)(9)(B) and 552b(c)(6),
Title 5 U.S.C., as amended. Premature
disclosure of potential candidates and
their qualifications, as well as the
discussions by the committee, could
significantly frustrate NIH’s ability to
recruit these individuals and the
consideration of personnel
qualifications, performance, and the
competence of individuals as candidates
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: April 28, 2017.
Open: 8:30 a.m. to 3:20 p.m.
Agenda: Clinical Center Tour (8:30–9:45)
Welcome and Board Chair’s Overview; NIH
Director’s Remarks, NIH CC CEO: First 100
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
17847
Days; CCRHB-Clinical Center Governing
Board Joint Session; Delayed Reporting Root
Cause Analysis; Clinical Trials Support
Realignment.
Place: Conference Room 6C6 (except for
Clinical Center Tour), Building 31, National
Institutes of Health, Bethesda, MD 20892.
Closed: 3:20 p.m. to 5:00 p.m.
Agenda: Identification of Candidates for
Leadership Roles.
Place: Conference Room 6C6, Building 31,
National Institutes of Health, Bethesda, MD
20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Dated: April 7, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07427 Filed 4–12–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, Office of Science
Policy; Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the meeting of the
National Science Advisory Board for
Biosecurity (NSABB).
Name of Committee: National Science
Advisory Board for Biosecurity.
Date: May 11, 2017.
Time: 2:00 p.m.–4:30 p.m. Eastern.
Agenda: Presentations and discussions
regarding: (1) The Blue Ribbon Panel draft
report on the 2014 variola virus incident on
the NIH Bethesda campus; (2) stakeholder
engagement on implementation of the U.S.
Government Policy for Institutional
Oversight of Life Sciences Dual Use Research
of Concern (DURC); and (3) other business of
the Board.
E:\FR\FM\13APN1.SGM
13APN1
]]>Agencies
[Federal Register Volume 82, Number 70 (Thursday, April 13, 2017)]
[Notices]
[Page 17847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07427]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of a meeting of the NIH
Clinical Center Research Hospital Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The portion of the meeting devoted to the identification and
evaluation of specific candidates for consideration for leadership
positions in the Clinical Center will be closed to the public in
accordance with the provisions set forth in section 552b(c)(9)(B) and
552b(c)(6), Title 5 U.S.C., as amended. Premature disclosure of
potential candidates and their qualifications, as well as the
discussions by the committee, could significantly frustrate NIH's
ability to recruit these individuals and the consideration of personnel
qualifications, performance, and the competence of individuals as
candidates would constitute a clearly unwarranted invasion of personal
privacy.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: April 28, 2017.
Open: 8:30 a.m. to 3:20 p.m.
Agenda: Clinical Center Tour (8:30-9:45) Welcome and Board
Chair's Overview; NIH Director's Remarks, NIH CC CEO: First 100
Days; CCRHB-Clinical Center Governing Board Joint Session; Delayed
Reporting Root Cause Analysis; Clinical Trials Support Realignment.
Place: Conference Room 6C6 (except for Clinical Center Tour),
Building 31, National Institutes of Health, Bethesda, MD 20892.
Closed: 3:20 p.m. to 5:00 p.m.
Agenda: Identification of Candidates for Leadership Roles.
Place: Conference Room 6C6, Building 31, National Institutes of
Health, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892, 301-496-4272,
woodgs@od.nih.gov.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
Dated: April 7, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07427 Filed 4-12-17; 8:45 am]
BILLING CODE 4140-01-P
